12:26
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies
08:34
Why the IRA Will Encourage Part D Plans to Prefer High-List, High-Rebate Drugs
07:31
Anti-Obesity Drugs and The Coming Battle Over Utilization Management
01:50
HMP Global Acquires Drug Channels Institute
08:22
The Economics of Copay Accumulators, Maximizers, and Alternative Funding Programs
08:34
How Discount Cards Work: A Primer on GoodRx and Its Competitors
05:23
Vertical Integration in Healthcare: 2023 Outlook for the Seven Major Players
06:54
The Biosimilar Boom and the Coming Humira Price War
01:03
Welcome to Drug Channels Video
03:36
Buy-and-Bill: Distributing and Reimbursing Provider-Administered Outpatient Drugs
X
About
Tags